Namikawa K, Kiyohara Y, Takenouchi T, Uhara H, et al. Final analysis of a phase II study of nivolumab in combination with ipilimumab for unresectable chemotherapy-naive advanced melanoma. J Dermatol 2020 Aug 18. doi: 10.1111/1346-8138.15514.
PMID: 32812243